Effect of certolizumab pegol over 96 weeks in patients with psoriatic arthritis with and without prior antitumour necrosis factor exposure

Effect of certolizumab pegol over 96 weeks in patients with psoriatic arthritis with and without prior antitumour necrosis factor exposure

Bibliographic Details
Main Authors: Mease, P, Deodhar, A, Fleischmann, R, Wollenhaupt, J, Gladman, D, Leszczyński, P, Vitek, P, Turkiewicz, A, Khraishi, M, FitzGerald, O, Landewé, R, de Longueville, M, Hoepken, B, Peterson, L, van der Heijde, D
Format: Online
Language:English
Published: BMJ Publishing Group 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4612702/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4612702/

Similar Items